Vitamin D insufficiency/deficiency has been observed worldwide at all stages of life. It has been characterized as a public health problem, since low concentrations of this vitamin have been linked to the pathogenesis of several chronic diseases. Several studies have suggested that vitamin D is involved in cardiovascular diseases and have provided evidence that it has a role in reducing cardiovascular disease risk. It may be involved in regulation of gene expression through the presence of vitamin D receptors in various cells, regulation of blood pressure (through renin-angiotensin system), and modulation of cell growth and proliferation including vascular smooth muscle cells and cardiomyocytes. Identifying correct mechanisms and relationships between vitamin D and such diseases could be important in relation to patient care and healthcare policies.
References
[1]
Melamed, M.L.; Michos, E.D.; Post, W.; Astor, B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med.？2008, 168, 1629–1637, doi:10.1001/archinte.168.15.1629. 18695076
[2]
Reis, J.P.; von Mühlen, D.; Michos, E.D.; Miller, E.R., 3rd; Appel, L.J.; Araneta, M.R.; Barrett-Connor, E. Serum vitamin D, parathyroid hormone levels, and carotid atheroscleros. Atherosclerosis？2009, 207, 585–590, doi:10.1016/j.atherosclerosis.2009.05.030. 19539290
[3]
Scragg, R.; Sowers, M.; Bell, C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am. J. Hypertens.？2007, 20, 713–719, doi:10.1016/j.amjhyper.2007.01.017. 17586404
[4]
Chen, S.; Glenn, D.J.; Ni, W.; Grigsby, C.L.; Olsen, K.; Nishimoto, M.; Law, C.S.; Gardner, D.G. Expression of the vitamin d receptor is increased in the hypertrophic heart. Hypertension？2008, 52, 1106–1112, doi:10.1161/HYPERTENSIONAHA.108.119602. 18936343
[5]
Wu-Wong, J.R.; Nakane, M.; Ma, J.; Ruan, X.; Kroeger, P.E. Effects of Vitamin D analogs on gene expression profiling in human coronary artery smooth muscle cells. Atherosclerosis？2006, 186, 20–28, doi:10.1016/j.atherosclerosis.2005.06.046. 16095599
[6]
Merke, J.; Milde, P.; Lewicka, S.; Hügel, U.; Klaus, G.; Mangelsdorf, D.J.; Haussler, M.R.; Rauterberg, E.W.; Ritz, E. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J. Clin. Invest.？1989, 83, 1903–1915, doi:10.1172/JCI114097. 2542376
[7]
Li, Y.C.; Kong, J.; Wei, M.; Chen, Z.F.; Liu, S.Q.; Cao, L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest.？2002, 110, 229–238. 12122115
Miller, W.L.; Portale, A.A. Genetic disorders of vitamin D biosynthesis. Endocrinol. Metab. Clin. North Am.？1999, 28, 825–840, doi:10.1016/S0889-8529(05)70104-3. 10609122
[10]
Holick, M.F. Evolution, biologic function, and recommended dietary allowances for vitamin D. In Vitamin D: Physiology, Molecular Biology, and Clinical Applications, 1st; Holick, M.F., Ed.; Humana: Totowa, NJ, USA, 1999; pp. 1–16.
[11]
Schuch, N.J.; Garcia, V.C.; Martini, L.A. Vitamin D and endocrine diseases. Arq. Bras. Endocrinol. Metabol.？2009, 53, 625–633, doi:10.1590/S0004-27302009000500015. 19768253
[12]
Mosekilde, L. Vitamin D and the elderly. Clin. Endocrinol.？2005, 62, 265–281, doi:10.1111/j.1365-2265.2005.02226.x.
[13]
Hollis, B.W. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J. Nutr.？2005, 35, 317–322.
[14]
Chapuy, M.C.; Preziosi, P.; Maamer, M.; Arnaud, S.; Galan, P.; Hercberg, S.; Meunier, P.J. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int.？1997, 7, 439–443, doi:10.1007/s001980050030. 9425501
[15]
Dawson-Hughes, B. Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women. Am. J. Clin. Nutr.？2004, 80, 1763S–1766S. 15585802
[16]
Heaney, R.P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am. J. Clin. Nutr.？2004, 80, 1706S–1709S. 15585791
[17]
Tangpricha, V.; Pearce, E.N.; Chen, T.C.; Holick, M.F. Vitamin D insufficiency among free-living healthy young adults. Am. J. Med.？2002, 112, 659–662, doi:10.1016/S0002-9343(02)01091-4. 12034416
[18]
Vieth, R.; Ladak, Y.; Walfish, P.G. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J. Clin. Endocrinol. Metab.？2003, 88, 185–191, doi:10.1210/jc.2002-021064. 12519850
[19]
Webb, A.R.; Kline, L.; Holick, M.F. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J. Clin. Endocrinol. Metab.？1988, 67, 373–378, doi:10.1210/jcem-67-2-373. 2839537
[20]
Cashman, K.D.; Hill, T.R.; Lucey, A.J.; Taylor, N.; Seamans, K.M.; Muldowney, S.; Fitzgerald, A.P.; Flynn, A.; Barnes, M.S.; Horigan, G.; Bonham, M.P.; Duffy, E.M.; Strain, J.J.; Wallace, J.M.; Kiely, M. Estimation of the dietary requirement for vitamin D in healthy adults. Am. J. Clin. Nutr.？2008, 88, 1535–1542, doi:10.3945/ajcn.2008.26594. 19064513
[21]
Cashman, K.D.; Wallace, J.M.; Horigan, G.; Hill, T.R.; Barnes, M.S.; Lucey, A.J.; Bonham, M.P.; Taylor, N.; Duffy, E.M.; Seamans, K.; Muldowney, S.; Fitzgerald, A.P.; Flynn, A.; Strain, J.J.; Kiely, M. Estimation of the dietary requirement for vitamin D in free-living adults >=64 y of age. Am. J. Clin. Nutr.？2009, 89, 1366–1374, doi:10.3945/ajcn.2008.27334. 19297462
[22]
Genaro, P.S.; Pereira, G.A.P.; Pinheiro, M.M.; Szjenfeld, V.L.; Martini, L.A. Relationship between nutrient intake and vitamin D status in osteoporotic women. Int. J. Vitam. Nutr. Res.？2007, 77, 376–381, doi:10.1024/0300-9831.77.6.376. 18622947
[23]
Peters, B.S.E.; Santos, L.C.; Fisberg, M.; Martini, L.A. Prevalence of vitamin D insufficiency in Brazilian Adolescents. Ann. Nutr. Metab.？2009, 54, 15–21. 19641346
[24]
Lewington, S.; Clarke, R.; Qizilbash, N.; Peto, R.; Collins, R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet？2002, 360, 1903–1913. 12493255
[25]
Giovannucci, E.; Liu, Y.; Hollis, B.W.; Rimm, E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med.？2008, 168, 1174–1180, doi:10.1001/archinte.168.11.1174. 18541825
[26]
Melamed, M.L.; Muntner, P.; Michos, E.D.; Uribarri, J.; Weber, C.; Sharma, J.; Raggi, P. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol.？2008, 28, 1179–1185, doi:10.1161/ATVBAHA.108.165886. 18417640
[27]
Kendrick, J.; Targher, G.; Smits, G.; Chonchol, M. 25-hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis？2009, 205, 255–260, doi:10.1016/j.atherosclerosis.2008.10.033. 19091317
[28]
Kim, D.H.; Sabour, S.; Sagar, U.N.; Adams, S.; Whellan, D.J. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am. J. Cardiol.？2008, 102, 1540–1544, doi:10.1016/j.amjcard.2008.06.067. 19026311
[29]
Pilz, S.; M？rz, W.; Wellnitz, B.; Seelhorst, U.; Fahrleitner-Pammer, A.; Dimai, H.P.; Boehm, B.O.; Dobnig, H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J. Clin. Endocrinol. Metab.？2008, 93, 3927–3935, doi:10.1210/jc.2008-0784. 18682515
[30]
Zittermann, A.; Schleithoff, S.S.; G？tting, C.; Dronow, O.; Fuchs, U.; Kuhn, J.; Kleesiek, K.; Tenderich, G.; Koerfer, R. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur. J. Heart Fail.？2008, 10, 321–327, doi:10.1016/j.ejheart.2008.01.013. 18304873
[31]
Semba, R.D.; Houston, D.K.; Bandinelli, S.; Sun, K.; Cherubini, A.; Cappola, A.R.; Guralnik, J.M.; Ferrucci, L. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr.？2010, 64, 203–209, doi:10.1038/ejcn.2009.140. 19953106
[32]
Reis, J.P.; von Mühlen, D.; Miller, E.R., 3rd; Michos, E.D.; Appel, L.J. Vitamin D Status and Cardiometabolic Risk Factors in the United States Adolescent Population. Pediatrics？2009, 124, e371–e379, doi:10.1542/peds.2009-0213. 19661053
[33]
Forman, J.P.; Giovannucci, E.; Holmes, M.D.; Bischoff-Ferrari, H.A.; Tworoger, S.S.; Willett, W.C.; Curhan, G.C. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension？2007, 49, 1063–1069, doi:10.1161/HYPERTENSIONAHA.107.087288. 17372031
[34]
Resnick, L.M.; Nicholson, J.P.; Laragh, J.H. Calcium metabolism in essential hypertension: relationship to altered renin system activity. Fed. Proc.？1986, 45, 2739–2745. 3533639
[35]
Burgess, E.D.; Hawkins, R.G.; Watanabe, M. Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am. J. Hypertens.？1990, 3, 903–905. 2081010
[36]
Imaoka, M.; Morimoto, S.; Kitano, S.; Fukuo, F.; Ogihara, T. Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin. Exp. Pharmacol. Physiol.？1991, 18, 631–641, doi:10.1111/j.1440-1681.1991.tb01637.x. 1835682
[37]
Lind, L.; H？nni, A.; Lithell, H.; Hvarfner, A.; S？rensen, OH.; Ljunghall, S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am. J. Hypertens.？1995, 8, 894–901, doi:10.1016/0895-7061(95)00154-H. 8541004
[38]
Kristal-Boneh, E.; Froom, P.; Harari, G.; Ribak, J. Association of calcitriol and blood pressure in normotensive men. Hypertension？1997, 30, 1289–1294, doi:10.1161/01.HYP.30.5.1289. 9369290
[39]
Kong, J.; Qiao, G.; Zhang, Z.; Liu, S.Q.; Li, Y.C. Targeted vitamin D receptor expression in juxtaglomerular cells suppresses renin expression independent of parathyroid hormone and calcium. Kidney Int.？2008, 74, 1577–1581, doi:10.1038/ki.2008.452. 19034301
[40]
Li, Y.C.; Qiao, G.; Uskokovic, M.; Xiang, W.; Zheng, W.; Kong, J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J. Steroid Biochem. Mol. Biol.？2004, 89-90, 387–392, doi:10.1016/j.jsbmb.2004.03.004. 15225806
[41]
Yuan, W.; Pan, W.; Kong, J.; Zheng, W.; Szeto, F.L.; Wong, K.E.; Cohen, R.; Klopot, A.; Zhang, Z.; Li, Y.C. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem.？2007, 282, 29821–29830, doi:10.1074/jbc.M705495200. 17690094
[42]
Fryer, R.M.; Rakestraw, P.A.; Nakane, M.; Dixon, D.; Banfor, P.N.; Koch, K.A.; Wu-Wong, J.R.; Reinhart, G.A. Differential inhibition of renin mRNA expression by paricalcitol and calcitriol in C57/BL6 mice. Nephron Physiol.？2007, 106, 76–81, doi:10.1159/000104875.
[43]
Zhou, C.; Lu, F.; Cao, K.; Xu, D.; Goltzman, D.; Miao, D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int.？2008, 74, 170–179, doi:10.1038/ki.2008.101. 18385669
[44]
Wu-Wong, J.R.; Nakane, M.; Ma, J.; Ruan, X.; Kroeger, P.E. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. Am. J. Physiol. Renal Physiol.？2007, 293, F1592–F1604, doi:10.1152/ajprenal.00492.2006. 17715259
[45]
Tarcin, O.; Yavuz, D.G.; Ozben, B.; Telli, A.; Ogunc, A.V.; Yuksel, M.; Toprak, A.; Yazici, D.; Sancak, S.; Deyneli, O.; Akalin, S. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. J. Clin. Endocrinol. Metab.？2009, 94, 4023–4030, doi:10.1210/jc.2008-1212. 19584181
[46]
Nibbelink, K.A.; Tishkoff, D.X.; Hershey, S.D.; Rahman, A.; Simpson, R.U. 1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myoc. J. Steroid Biochem. Mol. Biol.？2007, 103, 533–537, doi:10.1016/j.jsbmb.2006.12.099. 17276054
[47]
Mancuso, P.; Rahman, A.; Hershey, S.D.; Dandu, L.; Nibbelink, K.A.; Simpson, R.U. 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J. Cardiovasc. Pharmacol.？2008, 51, 559–564, doi:10.1097/FJC.0b013e3181761906. 18496147
[48]
Bodyak, N.; Ayus, J.C.; Achinger, S.; Shivalingappa, V.; Ke, Q.; Chen, Y.S.; Rigor, D.L.; Stillman, I.; Tamez, H.; Kroeger, P.E.; Wu-Wong, R.R.; Karumanchi, S.A.; Thadhani, R.; Kang, P.M. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc. Natl. Acad. Sci. U S A.？2007, 104, 16810–5, doi:10.1073/pnas.0611202104. 17942703
[49]
Gezmish, O.; Tare, M.; Parkington, H.C.; Morley, R.; Porrello, E.R.; Bubb, K.J.; Black, M.J. Maternal Vitamin D Deficiency Leads to Cardiac Hypertrophy in Rat Offspring. Reprod. Sci.？2010, 17, 168–176, doi:10.1177/1933719109349536. 19828430
[50]
Zittermann, A.; Frisch, S.; Berthold, H.K.; G？tting, C.; Kuhn, J.; Kleesiek, K.; Stehle, P.; Koertke, H.; Koerfer, R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr.？2009, 89, 1321–1327, doi:10.3945/ajcn.2008.27004. 19321573
[51]
Schleithoff, S.S.; Zittermann, A.; Tenderich, G.; Berthold, H.K.; Stehle, P.; Koerfer, R. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr.？2006, 83, 754–759. 16600924
[52]
Sugiura, S.; Inaguma, D.; Kitagawa, A.; Murata, M.; Kamimura, Y.; Sendo, S.; Hamaguchi, K.; Nagaya, H.; Tatematsu, M.; Kurata, K.; Yuzawa, Y.; Matsuo, S. Administration of alfacalcidol for patients with predialysis chronic kidney disease may reduce cardiovascular disease events. Clin. Exp. Nephrol.？2009, 24, 1–8.
[53]
LaCroix, A.Z.; Kotchen, J.; Anderson, G.; Brzyski, R.; Cauley, J.A.; Cummings, S.R.; Gass, M.; Johnson, K.C.; Ko, M.; Larson, J.; Manson, J.E.; Stefanick, M.L.; Wactawski-Wende, J. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci.？2009, 64, 559–567. 19221190
[54]
Autier, P.; Gandini, S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch. Intern. Med.？2007, 167, 1730–1737, doi:10.1001/archinte.167.16.1730. 17846391
Lind, L.; Wengle, B.; Ljunghall, S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study. Acta Med. Scand.？1987, 222, 423–427. 3321926
[57]
Pfeifer, M.; Begerow, B.; Minne, H.W.; Nachtigall, D.; Hansen, C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J. Clin. Endocrinol. Metab.？2001, 86, 1633–1637, doi:10.1210/jc.86.4.1633. 11297596
[58]
Kimura, Y.; Kawamura, M.; Owada, M.; Oshima, T.; Murooka, M.; Fujiwara, T.; Hiramori, K. Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern. Med.？1999, 38, 31–35, doi:10.2169/internalmedicine.38.31. 10052739
[59]
Thierry-Palmer, M.; Cephas, S.; Muttardy, F.F.; Al-Mahmoud, A. High dietary cholecalciferol increases plasma 25-hydroxycholecalciferol concentration, but does not attenuate the hypertension of Dahl salt-sensitive rats fed a high salt diet. J. Steroid Biochem. Mol. Biol.？2008, 111, 7–12, doi:10.1016/j.jsbmb.2008.04.002. 18554900
